Steven Cohen Rx Sight, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 446,976 shares of RXST stock, worth $15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

446,976

Previous 62,935 610.22%

Holding current value

$15 Million

Previous $3.79 Million 483.57%

% of portfolio

0.06%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.78 - $57.04 $15.7 Million - $21.9 Million	384,041 Added 610.22%	446,976 $22.1 Million
Q2 2024 Aug 14, 2024	BUY	$50.42 - $64.29 $2.34 Million - $2.98 Million	46,336 Added 279.15%	62,935 $3.79 Million
Q1 2024 May 15, 2024	SELL	$35.51 - $57.92 $8.06 Million - $13.2 Million	-227,116 Reduced 93.19%	16,599 $856,000
Q4 2023 Feb 14, 2024	SELL	$20.91 - $40.9 $8.62 Million - $16.9 Million	-412,230 Reduced 62.85%	243,715 $9.83 Million
Q3 2023 Nov 14, 2023	BUY	$27.05 - $33.37 $2.26 Million - $2.79 Million	83,502 Added 14.59%	655,945 $18.3 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $3.67 Million - $6.48 Million	224,275 Added 64.42%	572,443 $16.5 Million
Q1 2023 May 15, 2023	BUY	$12.58 - $16.68 $1.14 Million - $1.51 Million	90,468 Added 35.11%	348,168 $5.81 Million
Q4 2022 Feb 14, 2023	BUY	$9.93 - $14.2 $199,185 - $284,837	20,059 Added 8.44%	257,700 $3.27 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $2.66 Million - $3.77 Million	237,641 New	237,641 $2.85 Million
Q2 2022 Aug 15, 2022	SELL	$10.61 - $16.66 $185,675 - $291,550	-17,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.97 - $14.03 $156,975 - $245,525	17,500 New	17,500 $217,000

Others Institutions Holding RXST

# of Institutions

224

Shares Held

32.3M

Call Options Held

394K

Put Options Held

32K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $930M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account